Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes

Aziz Nazha,Rami S. Komrokji,Manja Meggendorfer,Xuefei Jia,Nathan Radakovich,Jacob Shreve,C Beau Hilton,Yasunubo Nagata,Betty K. Hamilton,Sudipto Mukherjee,Najla Al Ali,Wencke Walter,Stephan Hutter,Eric Padron,David A. Sallman,Teodora Kuzmanovic,Cassandra M. Kerr,Vera Adema,David P. Steensma,Amy E. DeZern,Gail J. Roboz,Guillermo Garcia-Manero,Harry P. Erba,Claudia Haferlach,Jaroslaw P. Maciejewski,Torsten Haferlach,Mikkael A Sekeres

Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes

2021

PURPOSEPatients with myelodysplastic syndromes (MDS) have a survival that can range from months to decades. Prognostic systems that incorporate advanced analytics of clinical, pathologic, and molec...

Keywords:

Oncology
MEDLINE
Internal medicine
Medicine
Myelodysplastic syndromes
Analytics

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations